Bob Dagher
Directeur Technique/Scientifique/R&D chez BRAINSTORM CELL THERAPEUTICS INC.
Fortune : 134 596 $ au 30/04/2024
Postes actifs de Bob Dagher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 16/04/2024 | - |
| Corporate Officer/Principal | 17/07/2023 | 16/04/2024 |
Historique de carrière de Bob Dagher
Anciens postes connus de Bob Dagher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 06/12/2021 | 01/01/2023 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2019 | 01/12/2021 |
| COVANCE INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 | 01/01/2019 |
| MedAvante-ProPhase, Inc. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Bob Dagher
| Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
| Université de Bordeaux | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| France | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| MedAvante-ProPhase, Inc. | |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Bob Dagher
- Expérience
